Aileen Ryan
Impact in
- Genetics top 10%
- Glioma Diagnosis and Treatment
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 19
- Cancer Immunotherapy and Biomarkers 14
- Peptidase Inhibition and Analysis 3
- CAR-T cell therapy research 3
-
- Cancer Research and Treatments 7
- Co-authors
- Ralph Venhaus (21 shared papers)Toni Ricciardi (21 shared papers)Mary Macri (20 shared papers)Paul Schwarzenberger (15 shared papers)Andrew J. Park (4 shared papers)Timothy F. Cloughesy (5 shared papers)Hui Gan (6 shared papers)Jennifer Clarke (6 shared papers)
- Journals
- Journal of Clinical Oncology (10 papers)Neuro-Oncology (3 papers)Cancer Immunology Research (3 papers)OncoImmunology (1 paper)Gynecologic Oncology (1 paper)
- Partner nations
- United StatesAustraliaSwitzerland
In The Last Decade
Aileen Ryan
21 papers receiving 226 citations
Peers
Comparison fields: 5 of 29
- Genetics 96
- Oncology 173
- Immunology 106
- Biotechnology 15
- Reproductive Medicine 14
Countries citing papers authored by Aileen Ryan
This map shows the geographic impact of Aileen Ryan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aileen Ryan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aileen Ryan more than expected).
Fields of papers citing papers by Aileen Ryan
This network shows the impact of papers produced by Aileen Ryan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aileen Ryan. The network helps show where Aileen Ryan may publish in the future.
Co-authors
The 25 scholars most cited alongside Aileen Ryan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 43 | |
| 2 | 2017 | 41 | |
| 3 | 2017 | 23 | |
| 4 | 2021 | 20 | |
| 5 | 2018 | 14 | |
| 6 | 2018 | 13 | |
| 7 | 2019 | 12 | |
| 8 | 2016 | 9 | |
| 9 | 2017 | 8 | |
| 10 | 2018 | 7 | |
| 11 | 2020 | 6 | |
| 12 | 2016 | 6 | |
| 13 | 2022 | 5 | |
| 14 | 2020 | 5 | |
| 15 | 2024 | 5 | |
| 16 | 2017 | 4 | |
| 17 | 2017 | 3 | |
| 18 | 2023 | 2 | |
| 19 | 2021 | 2 | |
| 20 | 2019 | 1 |
About Aileen Ryan
Aileen Ryan is a scholar working on Oncology, Biotechnology, Genetics, Immunology and Pulmonary and Respiratory Medicine, having authored 21 papers that have together received 230 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (14 papers), Cancer Research and Treatments (7 papers), Immunotherapy and Immune Responses (6 papers), Glioma Diagnosis and Treatment (5 papers), Peptidase Inhibition and Analysis (3 papers), Virus-based gene therapy research (3 papers), CAR-T cell therapy research (3 papers) and Nanoplatforms for cancer theranostics (2 papers). The work is most often cited by research in Genetics (96 citations), Oncology (173 citations), Immunology (106 citations), Biotechnology (15 citations) and Reproductive Medicine (14 citations). Aileen Ryan has collaborated with scholars based in United States, Australia and Switzerland. Frequent co-authors include Ralph Venhaus, Toni Ricciardi, Mary Macri, Paul Schwarzenberger, Andrew J. Park, Timothy F. Cloughesy, Hui Gan, Jennifer Clarke, Michael Lim and Gavin P. Dunn. Their work appears in journals such as Journal of Clinical Oncology, Neuro-Oncology, Cancer Immunology Research, OncoImmunology and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.